y 590 has been researched along with my 5445 in 1 studies
*MY 5445: potential platelet aggregation inhibitor [MeSH]
*MY 5445: potential platelet aggregation inhibitor [MeSH]
| Studies (y 590) | Trials (y 590) | Recent Studies (post-2010) (y 590) | Studies (my 5445) | Trials (my 5445) | Recent Studies (post-2010) (my 5445) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 25 | 0 | 6 |
| Protein | Taxonomy | y 590 (IC50) | my 5445 (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.975 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Bos taurus (cattle) | 6.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristol, JA; Cain, MH; Weishaar, RE | 1 |
1 review(s) available for y 590 and my 5445
| Article | Year |
|---|---|
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity | 1985 |